Core Viewpoint - Gauzy Ltd. is facing a class action lawsuit due to significant financial distress, including the initiation of insolvency proceedings for its French subsidiaries, which has led to a substantial drop in its stock price and allegations of misleading statements by the company's management [2][4]. Company Developments - On November 14, 2025, Gauzy announced that the Commercial Court of Lyon, France, ordered the commencement of insolvency proceedings for three of its subsidiaries in France, known as "Redressement Judiciaire" [2]. - The company indicated that these proceedings constitute a default under its existing senior secured debt facilities, which could lead to further financial complications if not addressed [2]. - As a result of these developments, Gauzy will not release its third-quarter financial results as previously scheduled [2]. Stock Performance - Following the announcement of the insolvency proceedings, Gauzy's share price fell by $2.00, or 49.8%, over two trading days, closing at $2.02 per share on November 17, 2025, with unusually high trading volume [3]. Legal Action - A class action lawsuit has been filed alleging that Gauzy's management made materially false and misleading statements regarding the company's financial health and failed to disclose critical information about its subsidiaries' inability to meet debt obligations [4]. - The lawsuit claims that the management's positive statements about the company's business were misleading and lacked a reasonable basis due to the impending insolvency [4]. - Investors who purchased Gauzy securities during the specified class period (March 11, 2025, to November 13, 2025) are encouraged to file a lead plaintiff motion by February 6, 2026 [5].

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Gauzy (GAUZ) To Contact Him Directly To Discuss Their Options If you purchased or acquired Gauzy securities between March 11, 2025 and November 13, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Forunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Bragar ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Gauzy Ltd. due to allegations of violations of federal securities laws, particularly concerning misleading statements and undisclosed financial difficulties of its subsidiaries [2][5]. Group 1: Company Financial Issues - Gauzy's three French subsidiaries reportedly lacked the financial means to meet their debts, leading to a substantial likelihood of insolvency proceedings [5]. - The initiation of insolvency proceedings on November 14, 2025, was announced, which constitutes a default under Gauzy's existing senior secured debt facilities [6]. - The company did not release its third-quarter 2025 financial results as scheduled due to these developments [6]. Group 2: Market Reaction - Following the announcement of insolvency proceedings, Gauzy's share price fell by $2.00 per share, nearly 50%, closing at $2.02 on November 17, 2025, with unusually high trading volume [7]. Group 3: Legal Proceedings - Investors who suffered losses during the specified period are encouraged to contact Faruqi & Faruqi to discuss their legal options, with a deadline of February 6, 2026, to seek the role of lead plaintiff in a federal securities class action [2][8].

Core Viewpoint - A class action lawsuit has been filed against Gauzy Ltd. regarding allegations of securities fraud and unlawful business practices [2]. Group 1: Lawsuit Details - The class action lawsuit involves Gauzy and certain officers and/or directors accused of engaging in securities fraud or other unlawful business practices [2]. - Investors have until February 6, 2026, to request to be appointed as Lead Plaintiff if they purchased or acquired Gauzy securities during the Class Period [2]. Group 2: Financial Performance and Impact - On November 14, 2025, Gauzy announced a delay in releasing its financial results for Q3 2025 due to insolvency proceedings ordered by the Commercial Court of Lyon, France, affecting three subsidiaries [4]. - Following the announcement of the insolvency proceedings, Gauzy's stock price dropped by $1.35 per share, or 33.58%, closing at $2.67 per share on the same day [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Gauzy Ltd. during the specified Class Period of the upcoming lead plaintiff deadline on February 6, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Gauzy securities between March 11, 2025, and November 13, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the specified deadline [2]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in this area [3]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [3]. Group 3: Case Allegations - The lawsuit alleges that Gauzy's management made false or misleading statements regarding the financial health of its French subsidiaries, which were unable to meet their debts, leading to potential insolvency proceedings [4]. - It is claimed that these misleading statements resulted in damages to investors when the true financial situation was revealed [4].

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Gauzy Ltd. (“Gauzy” or “the Company”) (NASDAQ: GAUZ) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Gauzy securities between March 11, 2025 and November 13, 202 ...

NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Gauzy Ltd. (NASDAQ: GAUZ) between March 11, 2025 and November 13, 2025, both dates inclusive (the “Class Period”), of the important February 6, 2026 lead plaintiff deadline. SO WHAT: If you purchased Gauzy securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Gauzy Ltd. due to allegations of violations of federal securities laws, particularly concerning misleading statements about the financial health of its subsidiaries [2][4]. Group 1: Company Financial Issues - The complaint alleges that three of Gauzy's French subsidiaries lacked the financial means to meet their debts, leading to a substantial likelihood of insolvency proceedings [4]. - The initiation of French insolvency proceedings (Redressement Judiciaire) against these subsidiaries was announced on November 14, 2025, which also constituted a default under Gauzy's existing senior secured debt facilities [5]. - Following the announcement, Gauzy's share price fell by $2.00, nearly 50%, closing at $2.02 on November 17, 2025, amid unusually heavy trading volume [6]. Group 2: Legal Proceedings and Investor Actions - Investors who purchased securities in Gauzy between March 11, 2025, and November 13, 2025, are encouraged to discuss their legal rights and options with Faruqi & Faruqi [1][2]. - There is a deadline of February 6, 2026, for investors to seek the role of lead plaintiff in the federal securities class action filed against Gauzy [2]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Gauzy's conduct [8].

Core Viewpoint - The company, Gauzy Ltd., is facing significant financial distress as three of its French subsidiaries have entered insolvency proceedings, which has led to a drastic decline in its share price and raised concerns about its ability to meet debt obligations [2][3][4]. Financial Distress and Legal Proceedings - Gauzy announced that the Commercial Court of Lyon has commenced Redressement Judiciaire against three of its French subsidiaries, indicating a lack of financial means to meet debts [2][3]. - The initiation of these insolvency proceedings is likely to trigger defaults under the company's existing senior secured debt facilities, raising concerns about the company's overall financial health [2][3]. Market Reaction - Following the announcement of the insolvency proceedings, Gauzy's share price fell by $2.00 per share, nearly 50%, closing at $2.02 on November 17, 2025, with unusually high trading volume [4].

Core Viewpoint - A class action has been filed against Gauzy Ltd. for allegedly misleading investors about its financial stability and business prospects during a specified period [1][2]. Group 1: Allegations and Financial Issues - The complaint alleges that Gauzy's French subsidiaries lacked the financial means to meet their debts, leading to a substantial likelihood of insolvency proceedings [2]. - The company disclosed that the commencement of insolvency proceedings in France constituted a default under its existing senior secured debt facilities, which could lead to further financial complications [3]. - Following the announcement of insolvency proceedings, Gauzy's share price dropped by $2.00, or 49.8%, closing at $2.02 per share [3]. Group 2: Class Action Participation - Shareholders wishing to serve as lead plaintiffs in the class action must submit their papers by February 6, 2026, but participation is not required to be eligible for recovery [4]. - The law firm Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses [5].